Vistagen Therapeutics Inc (VTGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2013 | 09-2013 | 06-2013 | 05-2013 | 03-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,143 | -1,274 | 186 | 0 | -12,887 |
| Depreciation Amortization | 396 | 228 | 106 | 0 | 289 |
| Accounts receivable | N/A | N/A | N/A | 0 | 106 |
| Other Working Capital | 1,763 | 1,144 | 580 | 0 | 1,624 |
| Other Operating Activity | -2,675 | -1,415 | -1,604 | 0 | 7,404 |
| Operating Cash Flow | $-1,659 | $-1,316 | $-732 | $0 | $-3,463 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10 | -34 | -10 | 0 | -135 |
| Investing Cash Flow | $-10 | $-34 | $-10 | $0 | $-135 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 250 | 250 | N/A | 0 | 3,222 |
| Debt Repayment | -125 | -93 | -43 | 0 | -514 |
| Common Stock Issued | 862 | 532 | 236 | 0 | 1,447 |
| Other Financing Activity | 64 | 30 | 0 | 0 | 0 |
| Financing Cash Flow | $1,051 | $719 | $193 | $0 | $4,156 |
| Beginning Cash Position | 638 | 638 | 638 | 0 | 81 |
| End Cash Position | 21 | 7 | 90 | 0 | 638 |
| Net Cash Flow | $-617 | $-632 | $-548 | $0 | $557 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,659 | -1,316 | -732 | 0 | -3,463 |
| Capital Expenditure | -10 | -34 | -10 | 0 | -135 |
| Free Cash Flow | -1,669 | -1,350 | -741 | 0 | -3,599 |